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Abstract
Objectives We conducted a Pakistan-wide communitybased survey on the prevalence of type 2 diabetes using
glycated haemoglobin (HbA1c) as the screening test. The
aim was to estimate diabetes prevalence across different
demographic groups as well as all regions of Pakistan.
Design, settings and participants Multistaged stratified
cluster sampling was used for the representative selection
of people aged ≥20 years, residing in 378 sampled
clusters of 16 randomly selected districts, in this crosssectional study. Eligible participants had blood drawn
for HbA1c analyses at field clinics near to their homes.
The oral glucose tolerance test (OGTT) was conducted
on a subsample of the participants. Overall and stratified
prevalence of type 2 diabetes and its association with risk
factors were estimated using logistic regression models.
Main outcome measures Prevalence of prediabetes and
type 2 diabetes.
Results Of 18 856 eligible participants the prevalence of
prediabetes was 10.91% (95% CI 10.46 to 11.36, n=2057)
and type 2 diabetes was 16.98% (95% CI 16.44 to 17.51,
n=3201). Overall, the mean HbA1c level was 5.62% (SD
1.96), and among newly diagnosed was 8.56% (SD 2.08).
The prevalence was highest in age 51–60 years (26.03%,
p<0.001), no formal education (17.66%, p<0.001), class
III obese (35.09%, p<0.001), family history (31.29%,
p<0.001) and female (17.80%, p=0.009). On multivariate
analysis, there was a significant association between type
2 diabetes and older age, increase in body mass index
and central obesity, positive family history, and having
hypertension and an inverse relation with education as a
categorical variable. On a subsample (n=1027), summary
statistics for diagnosis of diabetes on HbA1c showed a
sensitivity of 84.7%, specificity of 87.2% and area under
the receiver operating characteristic curve 0.86, compared
with OGTT.
Conclusions The prevalence of type 2 diabetes and
prediabetes is much higher than previously thought in
Pakistan. Comprehensive strategies need to be developed
to incorporate screening, prevention and treatment of type
2 diabetes at a community level.

Strengths and limitations of this study
►► Our study has the strength that we carried out gly-

cated haemoglobin (HbA1c) on all participants and
oral glucose tolerance test (OGTT) on a subsample.
►► Furthermore, this is the largest ever national prevalence study of type 2 diabetes mellitus from Pakistan
to date and the first community-based national
study to use HbA1c as the diagnostic tool.
►► The relatively low number (n=1027) of 75 g OGTT.
Nevertheless, the specificity and sensitivity of
HbA1c versus OGTT was good.
►► We had to exclude 16% of recruited participants because of anaemia.

Background
Type 2 diabetes mellitus is one of the most
common public health issues worldwide and
its incidence is on the rise, particularly in
middle-income and low-income countries.1
When associated with complications, type 2
diabetes can have a profound impact on the
person with consequences also for the society
as a whole. Diabetes was previously thought
to be a disease of the affluent and mostly
prevalent in urban areas but due to urbanisation, change in nutrition and a more sedentary lifestyle for many people, it has affected
middle-income and low-income nations,
including Pakistan.2
Pakistan is a South Asian country with
an area of 796 095 km2 and a population of
207.7 million people.3 In terms of population, Pakistan is the sixth most populous
country and is the 36th largest country by
geographical area in the world. Before 2018,
the only previous national diabetes survey
in Pakistan in 1999 (published in 2007),
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Methods
The Department of Diabetes, Endocrine and Metabolic
Diseases, Hayatabad and Department of Health, Government of Khyber Pakhtunkhwa, Pakistan with technical
support from Institute of Public Health, Khyber Medical
University Peshawar Pakistan, University of Manchester
UK and Pakistan Endocrine Society conducted a nationwide cross-sectional study for the prevalence of type 2
diabetes starting from April 2017 to November 2017.
Three teams of trained field workers under the supervision of epidemiologists collected basic demographic data
and blood samples from the selected sample. The study
sample was selected based on a stratified two-stage cluster
design, including all metropolitan cities of Pakistan and
randomly selected districts (both rural and urban settings)
within each province. The sample included districts from
central and south of Punjab province (Lahore, Multan,
Bahawalpur, Rahim Yar Khan), interior Sindh (Larkana,
Dadoo, Sukkur), central Sindh (Karachi), northern
Khyber Pakhtunkhwa (KP) (Haripur), central (Peshawar)
2

and southern KP province (Karak), Baluchistan province
(Quetta), capital territory (Rawalpindi-Islamabad), Azad
Jammu Kashmir (AJK) (Muzaffarabad), Frontier Region
Peshawar and the Khyber Agency in Federal Administered Tribal Area (FATA).
Sample size and sampling methodology
The sample size was estimated for the provinces of the
country based on recent census results. The sample size
was estimated based on an expected prevalence of 12%
with 20% relative precision and a design effect of 2.6 For a
95% CI and an additional adjustment of 32% for non-responders, keeping in view an exclusion rate due to an
expected high prevalence of anaemia, the sample size was
4407 approximated to 4500 in order to have 50 subjects
from each cluster. All provinces were included as was the
Federal territory. AJK and FATA were considered as one
province for the survey purpose because of their small
size of the population. The number of eligible subjects
was 4500×5=22 500.
Three districts were randomly selected from each province and the sample size was equally divided on these
districts. Fifteen hundred subjects (30 clusters, 50 subjects
per cluster) were examined in each district. The sample
was proportionately divided among urban and rural
areas. Probability proportionate to size (PPS) method was
used to select clusters from villages in the rural settings of
the district. In urban settings, clusters were selected from
charges and circles (defined in the national census) using
the PPS method.
Maps were obtained from the census office of selected
villages/charges/circles (V/C/C). Maps of each V/C/C
was divided into equal segments such that each segment
had approximately 50 persons aged 20 years and above.
One segment was randomly selected and every house
within the segment was included. All persons aged 20
years and above living in that house were examined until
the 50 number was reached. Any person who was absent
on the day of survey until evening, was terminally ill, who
fitted into exclusion criteria or who refused were marked
as non-responders.
Conditions that may affect HbA1c including anaemic
subjects with haemoglobin <120 g/L in women and
<140 g/L in men, self-reported renal and hepatic dysfunction, recent blood transfusion and use of erythropoietin,
age below 20 years or refusal to participate resulted in
exclusion. Face-to-face interview was conducted at the
participant’s home to collect information on demographics (including age, gender, residential area, formal
education, family history of diabetes and smoking status)
using a paper questionnaire in local languages. Eligible
participants were called to a central point established
in the hujra (local public gathering place), where their
haemoglobin was tested using the Mission Plus Haemoglobin Metre (reflectance photometer technique) (Acon
Laboratories, San Diego, USA) (coefficient of variance
(CV): 3%). Blood pressure was measured using an automated digital blood pressure monitor Konfort Model
Aamir AH, et al. BMJ Open 2019;9:e025300. doi:10.1136/bmjopen-2018-025300
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reported the prevalence of type 2 diabetes as 11% using
the oral glucose tolerance test (OGTT).4 5 Part of the
same survey separately reported the prevalence of type 2
diabetes in different provinces of Pakistan.4 6–8 The International Diabetes Federation (IDF) reported in its Atlas
5th edition the prevalence for Pakistan to be 6.8%, aged
20–79 years,9 but healthcare professionals with local
insight always believed this to be an underestimate. Subsequently, there were conflicting findings with prevalence
ranging from7.2% to 19.21% in different regions of the
country.5
The American Diabetes Association (ADA) criteria for
the diagnosis of diabetes require either fasting plasma
glucose (FPG) or 75 gm OGTT, which is time-consuming,
requires fasting and may not always be reproducible.10 11
In 2009, the International Expert Committee on diabetes
proposed new diagnostic criteria based on glycated
haemoglobin (HbA1c), which captures chronic glucose
exposure.12 The proposed diagnostic threshold of 6.5%
(48 mmol/mol) was based on retinopathy risk at different
levels of HbA1c as was the case with FPG and OGTT. This
report was followed by a recommendation from the ADA
that an HbA1c level of 6.5% (48 mmol/mol) be used as
the diagnostic cut-off for the diagnoses of diabetes (this
has not been validated in Pakistan).13
A previous national-level type 2 diabetes survey was
conducted in 1999 with a sample size of 5433 using
OGTT. In the study described in this paper, we investigated the prevalence of type 2 diabetes (using the HbA1c
test) and its distribution across gender, age, rural and
urban, education, body mass index (BMI) WHO and
Asian cut-offs, family history, smoking and blood pressure among a large sample across Pakistan, aged 20 years
and above. A subsample was tested to explore the diagnostic accuracy of HbA1c for diagnosis of type 2 diabetes,
compared with the 2-hour OGTT.

Open access

Definitions
Age was categorised into six groups: 20–30, 31–40,
41–50, 51–60 and 61 and above years. The residential
area was classified as urban and rural based on local
government criteria. Formal education status was self-reported and was categorised as no formal education,
primary, secondary and graduation/postgraduation.
BMI was categorised on WHO criteria (1995) into underweight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2),
overweight (25–29.9 kg/m2), class I obese (30–34.9 kg/
m2), class II obese (35–39.9 kg/m2) and class III obese
(>40 kg/m2). Waist circumference (WC) was categorised
into normal weight (0–93.99), overweight (94–102) and
obese (102 and above). Waist-to-hip ratio (WHR) was
categorised into normal weight (0–0.89), overweight
(0.90–0.99) and obese (1 and above).14 The family
history of diabetes was categorised to negative or positive
on the basis of the participant’s self-reporting, based on
physician’s diagnoses. Smoking status was categorised as
never, ex or current smoker. Systolic and diastolic blood
pressure was measured using a standard procedure and
hypertension was defined on a blood pressure measurement of ≥140/90 mm Hg or antihypertensive medication.
Patients were considered as known type 2 diabetes based
on self-reporting and/or being on dietary or exercise
advice, oral antidiabetes medications or insulin. This
self-reported group of patients could either be on single
medications or on different drug combinations or diet
and exercise therapy.
Type 2 diabetes was diagnosed based on HbA1c results
in keeping with the WHO levels for non-diabetes (<5.69%
DCCT aligned/38 mmol/mol International Federation
of Clinical Chemistry (IFFC) units), prediabetes (5.7%–
6.49% DCCT aligned/39–47 mmol/mol IFFC units),
diabetes (≥6.5% DCCT aligned/48 mmol/mol IFFC
units). For univariate and multivariate logistic regression models, diabetes was dichotomised to no (0; HbA1c
level <6.5) and yes (1; HbA1c level ≥6.5).
Statistical analyses
Differences in the characteristics of participants by
diabetes category were analysed using the χ² test for
Aamir AH, et al. BMJ Open 2019;9:e025300. doi:10.1136/bmjopen-2018-025300

categorical data and analysis of variance for continuous
data. We examined the association between diabetes and
risk factors, that is, age, gender, residence area, education, BMI, family history of diabetes, smoking, systolic
and diastolic blood pressure, using univariate and multivariate logistic regression models. Multivariate regression
analysis included all these variables.
Taking OGTT as the standard on a subsample, the diagnostic accuracy summary statistics (sensitivity, specificity,
area under the receiver operating characteristic (ROC)
curve, positive and negative predictive value) for the diagnosis of diabetes using HbA1c were determined. All statistical analyses were performed using Stata V.14 (StataCorp,
College Station, Texas, USA). Statistical significance was
defined as p<0.05 and analysis were adjusted for the
cluster design.
Patient and public involvement statement
Patients were not involved in the study conception or
design. There was consultation with interested representative public bodies but not with individual members of
the public.

Results
Of the 22 500 participants, 3644 (16%) were anaemic and
therefore excluded from the study. Out of the remaining,
18 856 participants aged 20 years and above were examined from 378 clusters of which 216 were rural generating
a response rate of 84%. The mean age was 45.23 years (SD
13.97 years). Most of the participants 10 116 (53.55%)
were men, 4148 (21.96%) were hypertensive and those
with higher blood pressure were advised to check their
blood pressure by visiting their doctors. Majority of the
participants, 13 834 (73.24%), had no formal education
and 1209 (6.40%) had graduated; 6010 (31.81%) had
a family history of type 2 diabetes. Overall, on WHO
cut-off 345 (1.83%) were underweight, 6839 (36.20%)
normal weight, 8038 (42.55%) overweight, 2864 (15.16%)
class I obese, 633 (3.35%) class II obese and 172 (0.91%)
class III obese. On WC cut-off (n=12 865), 8574 (66.64%)
were normal weight, 2318 (18.02%) were overweight and
1974 (15.34%) were obese. On central obesity cut-off
(WHR, n=12 865), 4271 (33.20%) were normal weight,
7467 (58.04%) were overweight and 1127 (8.76%) were
obese. Mean systolic blood pressure was 126.30 mm Hg
(SD 14.2) and diastolic blood pressure was 83.24 mm Hg
(SD 10.2).
Overall, 3201 subjects (16.98%, 95% CI 16.44 to
17.51) had type 2 diabetes based on HbA1c screening.
Prediabetes was present in 2057 subjects 10.91% (95%
CI 10.46 to 11.36). The mean HbA1c level of the entire
cohort (n=18 856) was 5.62% (SD 1.96), among known
type 2 diabetes (n=2179) had 8.68% (SD 2.70) and newly
diagnosed type 2 diabetes (n=1577) had 8.56% (SD 2.08).
The prevalence of diabetes differed significantly by age,
education, BMI, WC, WHR, family history and blood pressure (table 1) (figure 1). The prevalence of diabetes was
3
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AS-351 in the lying position with the average of three
readings was recorded. Weight in kilograms and height in
metres was recorded and used to calculate BMI.
Diabetes status was assessed for HbA1c on blood samples
using the National Glycohemoglobin Standardisation
Programme certified FIA 8000 immunoassay analyser
(lateral flow chromatography colloidal gold) traceable
to diabetes control and complication trial (DCCT) reference method (CV: 3%–5%). To compare the results
from HbA1c, 2-hour OGTT was conducted on a random
sample of participants from all clusters (n=1027) in the
specified standard laboratory using Cobas C311 (Roche
Diagnostics, Mannheim, Germany). Participants were
given vouchers for free OGTT test within 7 days in a
nearby laboratory.

Open access

Non-diabetic N (%)

Prediabetic N (%)

Diabetic N (%)

13 598 (72.11)

2057 (10.91)

3201 (16.98)

20–30

2772 (20.37)

218 (10.60)

176 (5.52)

31–40

3503 (25.74)

425 (20.66)

511 (16.01)

41–50

3802 (27.94)

654 (31.79)

1033 (32.37)

51–60

1955 (14.37)

412 (20.03)

833 (26.10)

61 and above

1576 (11.58)

348 (16.92)

638 (19.99)

Male

7363 (54.15)

1099 (53.43)

1638 (51.17)

Female

6235 (45.85)

958 (46.57)

1563 (48.83)

No formal education

9853 (72.41)

1516 (73.70)

2439 (76.43)

Primary

1936 (14.23)

354 (17.21)

452 (14.16)

Secondary

818 (6.01)

99 (4.81)

184 (5.77)

Graduation

1001 (7.36)

88 (4.28)

116 (3.64)

Urban

9117 (67.00)

1213 (58.97)

1932 (60.55)

Rural

4491 (33.00)

844 (41.03)

1259 (39.45)

10 325 (75.93)

1210 (58.82)

1320 (41.24)

3273 (24.07)

847 (41.18)

1881 (58.76)

12 682 (93.26)

1893 (92.03)

2937 (91.75)

P value

Age (years)
<0.001

Gender
0.010

Education
<0.001

Area
<0.001

Family history
Negative
Positive

<0.001

Smoking
Never

0.008

Ex-smoker

275 (2.02)

49 (2.38)

91 (2.84)

Current smoker

641 (4.71)

115 (5.59)

173 (5.40)

Systolic BP (mean±SD)

124.98

128.17

130.77

0.020

Diastolic BP (mean±SD)

82.75

84.13

84.84

0.006

279 (2.05)

31 (1.51)

35 (1.09)

Normal weight (18.5 to <25)

5137 (37.78)

668 (32.47)

1019 (31.83)

Overweight (25 to <30)

5884 (43.27)

850 (41.32)

1288 (40.24)

Class I obese (30 to <35)

1844 (13.56)

396 (19.25)

621 (19.40)

Class II obese (35 to <40)

372 (2.74)

83 (4.04)

178 (5.56)

82 (0.60)

29 (1.41)

60 (1.87)

Normal weight

6787 (70.88)

645 (51.68)

1142 (55.93)

Overweight

1676 (17.50)

285 (22.84)

357 (17.48)

Obese

1113 (11.62)

318 (25.48)

543 (26.59)

Normal weight

3219 (33.62)

394 (31.57)

658 (32.22)

Overweight
Obese

5528 (57.73)
828 (8.65)

768 (61.54)
86 (6.89)

1171 (57.35)
213 (10.43)

2

BMI (kg/m )
Underweight (<18.5)

Class III obese (≥40)

<0.001

Waist circumference*
<0.001

Waist-to-hip ratio*
0.002

*n for waist circumference and waist-to-hip ratio is 12 865.
BP, blood pressure.
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Table 1 Characteristics of the participants by diabetes categories (n=18 856)

Open access

highest in age 51–60 years (26.03%, p<0.001), no formal
education (17.73%, p<0.001), class III obese (32.19%,
p<0.001) and with a positive family history of diabetes
(31.34%, p<0.001) (figure 1). There were also statistically
significant differences in diabetes prevalence by gender
(female 17.85%, p=0.01), rural/urban (rural 19.09%,
p<0.001) and smoking status (p=0.008).
On univariate logistic regression analysis, there was a
significant association between age, gender, education,
BMI category, family history, blood pressure and type 2
diabetes (p<0.005) (table 2).
On multivariate logistic regression, there was significantly higher risk of diabetes with age (adjusted OR 2.03,
95% CI 3.39 to 4.87 and 4.93, p<0.001, aged 31–40, 41–50,
51–60 and 61 years and above, respectively, compared
with aged 20–30 years), BMI (adjusted OR 1.54, 95%
CI 2.13 to 2.44, p<0.001 for class I, class II and class III
obese, respectively, compared with normal weight) with
evidence of a dose-response relationship. Similarly, there
was a significantly higher risk of diabetes with lower
educational attainment (adjusted OR 1.83, 95% CI 1.39
to 1.57, no formal education, primary and secondary
education, respectively, compared with graduates). There
was a significantly higher risk of diabetes in people with
Aamir AH, et al. BMJ Open 2019;9:e025300. doi:10.1136/bmjopen-2018-025300

a positive family history (adjusted OR 3.94, 95% CI 3.6 to
4.3, p<0.001), than with no family history of diabetes.
There was no significant association with smoking and
rural/urban area.
Among 1029 participants who were tested for 2-hour
OGTT, in addition to HbA1c, the mean 2-hour OGTT
was 200.26 (SD 91.7), and the median was 178 (IQR 100).
Taking the OGTT as the gold standard, HbA1c recommended cut-off for diabetes showed a sensitivity of 84.7%
(95% CI 80.8 to 88) and specificity of 87.2% (95% CI
84.3 to 89.8%), area under the ROC 0.86 (95% CI 0.84 to
0.88), positive predictive value 81.9% (95% CI 77.9 to
85.4) and negative predictive value 89.3 (95% CI 86.5 to
91.6) (table 3).

Discussion
This is the first community-based national study done in
the region based on HbA1c and with the eligible 18 856
subjects from that country makes this as the largest study
to date from Pakistan. The prevalence of type 2 diabetes
across Pakistan was 16.98% (95% CI 16.44 to 17.51) and
prediabetes was 10.91% (95% CI 10.46 to 11.36). This is
5
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Figure 1 Prevalence of diabetes (diagnosed by glycated haemoglobin (HbA1c) ≥6.5% diabetes control and complication
trial (DCCT) aligned/48 mmol/mol IFFC units) by regions of Pakistan, age, gender, education, family history of diabetes,
hypertension, waist circumference, waist-to-hip ratio and body mass index (n=18 856). KP, Khyber Pakhtunkhwa.
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Univariate
OR (95% CI)

Multivariate
P value

OR (95% CI)

P value

Age (years)
20–30

1

31–40

2.21 (1.8 to 2.6)

<0.001

2.03 (1.7 to 2.4)

<0.001

41–50

3.93 (3.3 to 4.6)

<0.001

3.39 (2.9 to 4.0)

<0.001

51–60

5.97 (5.0 to 7.1)

<0.001

4.87 (4.1 to 5.8)

<0.001

61 and above

5.63 (4.7 to 6.7)

<0.001

4.93 (4.1 to 6.0)

<0.001

1

Gender
Male

1

Female

1.12 (1.0 to 1.2)

0.003

1
1.04 (0.9 to 1.1)

0.334

No formal education

2.02 (1.6 to 2.4)

<0.001

1.83 (1.5 to 2.3)

<0.001

Primary

1.85 (1.49 to 2.3)

<0.001

1.39 (1.1 to 1.8)

0.006

Secondary

1.89 (1.47 to 2.4)

<0.001

1.57 (1.2 to 2.0)

0.001

Graduation

1

Education

1

Area
Urban

1

Rural

1.26 (1.16 to 1.34)

1
<0.001

1.08 (0.9 to 1.2)

0.084

Family history
Negative

1

Positive

3.98 (3.6 to 4.3)

1
<0.001

3.94 (3.6 to 4.3)

<0.001

Smoking
Never

1

1

Ex-smoker

1.39 (1.1 to 1.8)

0.006

1.13 (0.9 to 1.5)

0.323

Current smoker

1.13 (0.9 to 1.3)

0.14

1.06 (0.9 to 1.3)

0.571

Systolic BP

1.02 (1.021 to 1.026)

<0.001

1.01 (1.01 to 1.02)

Diastolic BP

1.01 (1.01 to 1.02)

<0.001

0.99 (0.9 to 1.0)

0.310

0.71 (0.5 to 1.0)

0.077

<0.001

BMI (kg/m2)
Underweight (<18.5)

0.64 (0.4 to 0.9)

Normal weight (18.5 to <25)

1

0.001

Overweight (25 to <30)

1.08 (0.9 to 1.2)

0.06

1.06 (0.9 to 1.1)

0.182

Class I obese (30 to <35)

1.57 (1.4 to 1.7)

<0.001

1.54 (1.3 to 1.7)

<0.001

Class II obese (35 to <40)

2.22 (1.8 to 2.6)

<0.001

2.13 (1.7 to 2.6)

<0.001

Class III obese (≥40)

3.07 (2.2 to 4.2)

<0.001

2.44 (1.7 to 3.5)

<0.001

1

WC*
Normal weight

1

1

Overweight

1.18 (1.04 to 1.34)

0.01

0.98 (0.8 to 1.1)

0.774

Obese

2.46 (2.19 to 2.77)

<0.001

1.86 (1.6 to 2.2)

<0.001

WHR*
Normal weight

1

Overweight
Obese

1.02 (0.92 to 1.13)
1.27 (1.07 to 1.51)

1
0.40
0.005

0.8 (0.7 to 0.9)
1.13 (0.9 to 1.4)

<0.001
0.205

*n for WC and WHR is 12 865. The following variables were included in the multivariate regression: age, gender, education, residence area,
family history of diabetes, smoking, systolic BP and diastolic BP and BMI.
BMI, body mass index; BP, blood pressure; DCCT, diabetes control and complication trial; HbA1c, glycated haemoglobin; WC, waist
circumference; WHR, waist-to-hip ratio.
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Table 2 Logistic regression analysis of the participant characteristics associated with having diabetes (HbA1c≥6.5% DCCT
aligned/48 mmol/mol IFFC units) (n=18 856)

Open access

95% CI
Prevalence
Sensitivity

Pr (A)
Pr (+|A)

40.6%
84.7%

37.6
80.8

43.7
88.0

Specificity

Pr (−|N)

87.2%

84.3

89.8

Area under the ROC

(Sens.+Spec.)/2

0.86

0.84

0.88

Likelihood ratio (+)

Pr (+|A)/Pr (+|N)

6.62

5.36

8.18

Likelihood ratio (−)

Pr (−|A)/Pr (−|N)

0.18

0.14

0.22

OR

LR (+)/LR (−)

37.62

26.34

53.73

81.9%
89.3%

77.9
86.5

85.4
91.6

Positive predictive value Pr (A|+)
Negative predictive
Pr (N|−)
value

HbA1c, glycated haemoglobin; OGTT, oral glucose tolerance test; ROC, receiver operating characteristic.

higher than found in the only previous national survey
conducted in1999 (n=5433) using OGTT. There was a
significantly higher risk of type 2 diabetes with increasing
systolic blood pressure, age, BMI, WC, WHR with evidence
of a dose-response relationship. Similarly, there was a
significant inverse relationship of type 2 diabetes with the
level of formal education. The risk of diabetes increased
2.68 times with a prior family history. The HbA1c level
had good sensitivity and specificity level for the diagnosis
of type 2 diabetes compared with a 2-hour OGTT level
and is therefore valid in community settings for screening
purposes.
We have noted the findings of Basit et al.15 The methodology for that recently published study was based on
75 g OGTT for glucose handling as opposed to HbA1c
used in our study. While the prevalence of diabetes and
prediabetes is different in the two studies, the point that
both studies make is that both diabetes and prediabetes
are much more prevalent than previously thought.
The previous national prevalence study conducted in
1999 used OGTT where almost 80% of the subjects were
women as the test was conducted in the morning time.4
In contrast, our study screening was done all through the
day so that working men had an equal opportunity to be
part of the study. They constituted 50% of the study population. OGTT is the gold standard for the type 2 diabetes
screening but because of the length of time which is
required for the test and the fact that the person must
be fasting, it is very difficult to perform in many community settings in Pakistan. Also, the high temperatures in
South Asia make it difficult to keep the sample stable for
transportation to the laboratory. To minimise the effect of
temperature and transportation errors on HbA1c, all tests
were conducted in the field.
Recently, a study carried out in 15 states of India showed
that the prevalence of type 2 diabetes ranged between 4%
and 13.6% and showed variation due to age, male sex,
obesity and family history using capillary fasting blood
glucose (FBG) for diagnosis.16 A capillary blood sample
for epidemiological studies is not an ideal test but the
Aamir AH, et al. BMJ Open 2019;9:e025300. doi:10.1136/bmjopen-2018-025300

authors acknowledged the logistic hindrance in carrying
out venous sample test in the field. A high prevalence in
another Indian study was reported ranging from 12.1% to
14% for diabetes using OGTT on a sample size of 11 216
subjects.17
A study conducted in Bangladesh based on capillary
fasting level found a prevalence of type 2 diabetes of 4.3%
in a rural setting.18 Risk factors were positive family history
for diabetes, age, high BMI and low socioeconomic status,
similar to our study. Although these are geographically
distant areas, the risk factors showed commonality in both
studies, which suggests these risk factors as an important
tool for mass screening.19
The age-standardised and sex-standardised prevalence
of type 2 diabetes for Sri Lankans was 10.3% based on
OGTT.20 The risk factors were almost the same as seen in
our study. The investigators found dysglycaemia in almost
21.8% participants and predicted that this would lead to a
higher prevalence of type 2 diabetes mellitus in the years
to come. Another study from Sri Lanka indicated a prevalence of 14.2% basis of FBG.21 FBG as well as, OGTT
blood glucose levels, may not be reproducible in an epidemiological survey if the individual are changing lifestyle
in terms of diet and exercise. The use of HbA1c in our
study makes our study more scientific, addressing issues
pertaining to sampling errors in the local environment.
The Asian population is known to have a significantly
higher risk of developing diabetes and its related complications as predicted by IDF projections.1 It makes it very
important from a public health point of view to identify
high-risk individuals at an early stage. The HbA1c test has
been used successfully in community settings.22 A national
health survey in New Zealand in 2008–2009 used HbA1c
to identify high-risk individuals with diabetes and prediabetes.23 A study in Japan revealed that a combination of
tests including FBG and HbA1c yields more diabetes cases
compared with any of these tests alone.24
WHO experts have accepted HbA1c as a diagnostic tool
provided quality assurance tests are in place and there
are no conditions present, which preclude its accurate
7
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Table 3 Summary statistics for diabetes diagnosed by HbA1c compared with diabetes diagnosed by 2-hour OGTT (n=1027)
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Strengths and limitations
Our study has the strength that we carried out HbA1c on
all participants and OGTT on a subsample. Furthermore,
this is the largest ever national prevalence study of type 2
diabetes mellitus from Pakistan and the first community-based national study to use HbA1c as the diagnostic
tool.
Limitations are the relatively low number (n=1027) of
75 g OGTT. Nevertheless, the specificity and sensitivity of
HbA1c versus OGTT was good. We had to exclude 16% of
recruited participants because of anaemia.
The central Government of Pakistan developed and
agreed on non-communicable diseases (NCD) National
Action Plan including diabetes; however, it was never
implemented. After the 18th Amendment in the constitution of Pakistan in 2010, provinces are responsible for
making and implementing their own health policies and
the role of central Government is limited to coordination among the different provinces.29 There is a dire
need that based on the agreed NCD National Action
Plan each province should build their capacity for implementing it at both primary and secondary level. Pakistan
is a signatory to the Sustainable Development Goals 2030
document, which outlines among its goals, increasing
access to universal health coverage, increasing coverage
of health insurance programme and adopting a family
medicine approach. When implemented, these will be
major steps towards prevention and control of diabetes
and all NCD.
8

Conclusions
This national diabetes prevalence study is the first one in
the region using HbA1c identified a huge population of
type 2 diabetes and prediabetes group. The prevalence
of type 2 diabetes and prediabetes is much higher than
previously thought in Pakistan. Comprehensive strategies
need to be developed to incorporate screening, prevention and treatment of type 2 diabetes at community level.
Those who are obese, with no formal education, older,
family history of diabetes and hypertensive merit close
attention and timely intervention.
HbA1c is an applicable test in community settings in
middle-income and low-income countries and it has a
good correlation with 2-hour OGTT. Our findings have
the potential to influence policy in middle-income and
low-income countries and induce a shift towards the
prevention and control of NCD.
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measurement. The New Zealand Society for the study
of diabetes and the Australian Diabetes Society have
already endorsed HbA1c as a test for the diagnosis of
diabetes.25 26 Recently, a prevalence study done in Korea
concluded that FBG testing results in underestimation of
diabetes and prediabetes.27 This study suggested the use
of standardised HbA1c as a diagnostic tool for diagnosis
of type 2 diabetes.
We found that HbA1c had a good sensitivity and specificity level for diagnoses of diabetes compared with the
OGTT. HbA1c has the advantage of being a simple test
and less time-consuming, making it an ideal test for
community surveys in our populations. In Pakistan, as
there is no effective primary care (general/family practice) structure most of the population does not undergo
primary screening for diabetes. Sometimes as the diagnosis is not made, people may present to tertiary care with
complications.
Thus, there is a strong case for applying HbA1c for
screening purposes in the community setting. There
will always be an argument about the cost of the test and
whether this to be used for screening purposes. However,
particularly those at social disadvantage need to undergo
screening to improve the diagnosis and timely treatment
of diabetes.28 Early diagnosis will also reduce diabetes-related complications.
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